Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 60Lung Neoplasms 31Colorectal Neoplasms 26Prostatic Neoplasms 24Colonic Neoplasms 18Rectal Neoplasms 16Carcinoma, Non-Small-Cell Lung 16Uterine Cervical Neoplasms 15Neoplasms 14Lymphoma 11Depression 10Urinary Bladder Neoplasms 9Unspecified Adult Solid Tumor, Protocol Specific 9Endometrial Neoplasms 9Ovarian Neoplasms 8Leukemia 8Hematologic Neoplasms 8Fatigue 8Breast Carcinoma In Situ 8Anxiety Disorders 8Pancreatic Neoplasms 7Pain 7Melanoma 7Leukemia, Myeloid, Acute 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Papillomavirus Infections 6Obesity 6Multiple Myeloma 6Carcinoma, Ovarian Epithelial 6Small Cell Lung Carcinoma 5

Interventions

Adalimumab 19Etanercept 16Methotrexate 11Infliximab 8tocilizumab 7Rituximab 7golimumab 6Abatacept 6tofacitinib 5Tumor Necrosis Factor Inhibitors 5olokizumab 4Certolizumab Pegol 4Antirheumatic Agents 3Saline Solution 2RC-18 2Nivolumab 2Leflunomide 2veltuzumab 1upadacitinib 1secukinumab 1sarilumab 1mavrilimumab 1entecavir 1cabozantinib 1baricitinib 1andecaliximab 1Vitamin D 1Vaccines 1TACI receptor-IgG Fc fragment fusion protein 1Syringes 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Arthritis, Rheumatoid × Early Intervention, Educational × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡